Severe Hyponatremia with Normokalemia in Pembrolizumab-Lenvatinib Combination Therapy for Metastatic Renal Cell Carcinoma: A Case of Suspected Secondary Adrenal Insufficiency and Clinical Differentials. OAIJMR [Internet]. 2025 Nov. 27 [cited 2026 Aug. 16];6(1):35-50. Available from: https://hmpublisher.com/index.php/OAIJMR/article/view/826